Researchers are using deep learning to assess retinal microvasculature in Fabry disease, aiming to correlate retinal patterns with disease biomarkers and cerebral small vessel disease lesions. This approach could provide new insights into the disease's impact on the body.
By linking retinal findings with broader disease markers, researchers may uncover more about how Fabry disease affects the body. This non-invasive method could lead to better monitoring and management strategies for patients. The study highlights the potential of advanced technologies in understanding vascular aspects of the disease (Li et al., 2025).
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:
